So what you’re trying to say is when two companies have the same/similar intrinsic value, you buy the one with the lowest share price. Should’ve just said that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025